Corcept Therapeutics (CORT) Interest Coverage Ratio (2010 - 2017)
Corcept Therapeutics' (CORT) quarterly Interest Coverage Ratio came in at 130.56 in Q2 2017, up 4497.35% year-on-year from 2.84 in Q2 2016, and up 519.75% quarter-over-quarter from 21.07 in Q1 2017.
Corcept Therapeutics (CORT) Interest Coverage Ratio (2010 - 2017) Analysis & Trends
Corcept Therapeutics has disclosed Interest Coverage Ratio across 8 years of filings, most recently posting 130.56 for Q2 2017.
- Interest Coverage Ratio for Q2 2017 came in at 130.56, up 4497.35% year-over-year; the trailing twelve-month figure through Mar 2018 was 705.2 (up 8036.4% YoY), and the FY2016 annual result was 4.99, up 529.91% from the prior year.
- Interest Coverage Ratio came in at 130.56 for Q2 2017 at Corcept Therapeutics, up from 21.07 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 130.56 in Q2 2017 to a low of 12.01 in Q1 2014.
- The 5-year median for Interest Coverage Ratio is 2.64 (2014), against an average of 5.83.
- Across the five-year window, Interest Coverage Ratio slipped 25.19% in 2014 and soared 4497.35% in 2017, its largest moves.
- Corcept Therapeutics' Interest Coverage Ratio stood at 9.17 in 2013, then surged by 58.97% to 3.76 in 2014, then jumped by 163.43% to 2.39 in 2015, then soared by 411.86% to 12.21 in 2016, then surged by 969.11% to 130.56 in 2017.
- The last three Interest Coverage Ratio figures came in at 130.56 (Q2 2017), 21.07 (Q1 2017), and 12.21 (Q4 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Corcept Therapeutics | 8.35 Bn | 8.01 Bn | 162.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 130.56 |
| Mar 31, 2017 | 21.07 |
| Dec 31, 2016 | 12.21 |
| Sep 30, 2016 | 6.31 |
| Jun 30, 2016 | 2.84 |
| Mar 31, 2016 | 0.97 |
| Dec 31, 2015 | 2.39 |
| Sep 30, 2015 | 0.15 |
| Jun 30, 2015 | -1.51 |
| Mar 31, 2015 | -5.04 |
| Dec 31, 2014 | -3.76 |
| Sep 30, 2014 | -5.65 |
| Jun 30, 2014 | -6.78 |
| Mar 31, 2014 | -12.01 |
| Dec 31, 2013 | -9.17 |
| Sep 30, 2013 | -8.35 |
| Jun 30, 2013 | -9.68 |
| Mar 31, 2013 | -9.59 |
| Dec 31, 2012 | -8.72 |
| Sep 30, 2012 | -12.33 |